Locke Lord advised Imugene Ltd. on the transaction.Precision BioSciences, Inc. (Nasdaq: DTIL) announced it has completed a transaction with Imugene Limited (ASX: IMU) for global rights to…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
